Monica Bertagnolli

Insider Reports History

Entity
Individual
Location
C/O Leap Therapeutics, Inc., 47 Thorndike Street, Suite B1 1, Cambridge, MA
Signature
/s/ Tami Chen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Monica Bertagnolli:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 998 $65.6K $65.70 Jul 8, 2022 Direct
LEAP THERAPEUTICS, INC. Director Stock Option (Right to Buy) 55K Jan 31, 2022 Direct

Insider Reports Filed by Monica Bertagnolli

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTRA Natera, Inc. Jul 8, 2022 1 $0 4/A Sep 2, 2022 Director
NTRA Natera, Inc. May 27, 2022 1 $0 4 Jun 1, 2022 Director
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 Director
NTRA Natera, Inc. Nov 17, 2021 2 $0 4 Nov 19, 2021 Director
LPTX LEAP THERAPEUTICS, INC. Sep 8, 2021 2 $0 4 Sep 10, 2021 Director
NTRA Natera, Inc. May 28, 2021 2 $0 4 Jun 2, 2021 Director